Benzimidazole derivatives

Details Benzimidazole derivatives Benzimidazole derivatives

2011-03-15

2011-03-15

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S394000

Reexamination Certificate

active

07906654

ABSTRACT:
Provided herein are compounds in accord with Formula I:that are useful in the treatment of pain.

REFERENCES:
patent: 3624103 (1971-11-01), De Martiis et al.
patent: 3839347 (1974-10-01), Fisher et al.
patent: 4722929 (1988-02-01), Austel et al.
patent: 4738981 (1988-04-01), Horwell
patent: 6794404 (2004-09-01), Beaulieu et al.
patent: 2003/0149050 (2003-08-01), Jagtap et al.
patent: 2003/0158188 (2003-08-01), Lee et al.
patent: 2004/0092569 (2004-05-01), Demaine et al.
patent: 2004/0152690 (2004-08-01), Balan et al.
patent: 2004/0248983 (2004-12-01), Morie et al.
patent: 2006/0205802 (2006-09-01), Liu et al.
patent: 2006/0287377 (2006-12-01), Besidski
patent: 2007/0066586 (2007-03-01), Tokumasu et al.
patent: 2008/0015222 (2008-01-01), Besidski et al.
patent: 2300521 (1973-07-01), None
patent: 0149200 (1984-12-01), None
patent: 0419210 (1991-03-01), None
patent: 1312601 (2003-05-01), None
patent: 0882718 (2005-08-01), None
patent: 1186504 (1970-04-01), None
patent: 94/22859 (1994-10-01), None
patent: 99/00115 (1999-01-01), None
patent: 01/12189 (2001-02-01), None
patent: 01/85722 (2001-11-01), None
patent: 01/96336 (2001-12-01), None
patent: 0250031 (2002-06-01), None
patent: 02/072536 (2002-09-01), None
patent: 02/085866 (2002-10-01), None
patent: 02/090326 (2002-11-01), None
patent: 02/100819 (2002-12-01), None
patent: 02/100822 (2002-12-01), None
patent: 03/014064 (2003-02-01), None
patent: 03/022809 (2003-03-01), None
patent: 03/027076 (2003-04-01), None
patent: 03/049702 (2003-06-01), None
patent: 03/053945 (2003-07-01), None
patent: 03/068749 (2003-08-01), None
patent: 2004/000828 (2003-12-01), None
patent: 2004/024154 (2004-03-01), None
patent: 2004/024710 (2004-03-01), None
patent: 2004100865 (2004-11-01), None
patent: 2004/108712 (2004-12-01), None
patent: 2005/021539 (2005-03-01), None
patent: 2005/095327 (2005-12-01), None
patent: 2006033620 (2006-03-01), None
patent: 2007073303 (2007-06-01), None
Caterina, et al., “The capsaicin receptor: a heat-activated ion channel in the pain pathway.” Nature (1997) v. 389, p. 816-824.
Hwang, et al., “Hot channels in airways: pharmacoloty of the vanilloid receptor”. Curr Opin Pharmacol (2002), June, 2 (3), p. 235-242.
Rashid, et al., “Novel Expression of Vanilloid Receptor 1 on Capsaicin-Insensitive Fibers Accounts for the Analgesic Effect of Capsaicin Cream in Neuropathic Pain.” J. Pharmacol Exp Ther. Mar. 2003 304(3), p. 940-948.
Szallasi, A., “Vanilloid (Capsaicin) Receptors in Health and Disease”. Am J. Clin Pathol (2002) 118, p. 110-121.
Tominaga, et al., “The cloned capsaicin receptor integrates multiple pain-producing stimuli.” Neuron (1998) v. 21, p. 531-543.
Walker, K. M., et al., “The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.” J. Pharmacol Exp Ther. Jan. 2003 304(1), p. 56-62.
Yiangou, et al., “Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder.” BJU Intl (2001), June 87(9), p. 774-779.
Non-final Office Action mailed on Jan. 7, 2008, for U.S. Appl. No. 10/556,229, AstraZeneca ref. No. 101062-1P US.
Non-final Office Action dated Jul. 16, 2007, for U.S. Appl. No. 10/556,229, AstraZeneca ref. No. 101062-1P US.
Gallard, et at., Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 18, No. 2 . 2003, “New N-Pyridinyl (methyl)-N1-Substituted . . . Systemic anti-Inflammatory Agents”, pp. 201-208.
T.L. Gilchrist, “Heterocyclic Chemistry”, 2nd Edition, Longman Scientific andTechnical (1992), pp. 248-282.
Non-final Office Action mailed on May 16, 2008, for U.S. Appl. No. 10/557,806, AstraZeneca reference No. 101101-1P US.
Co-pending U.S. Publication No. 2006-0287377, published on Dec. 21, 2006.
Co-pending U.S. Appl. No. 11/614,346, filed on Dec. 21, 2006.
Co-pending U.S. Publication No. 2008-0015222, published on Jan. 17, 2008.
Co-pending U.S. Publication No. 2006-0205802, published on Sep. 14, 2006.
Non-Final Office Action mailed on Jul. 23, 2008 for U.S. Appl. No. 10/557,806, AstraZeneca reference No. 101101-1P US.
Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany; XP002291482, BRN 838602 abstract and Kamel et al, J. Prakt. Chem., vol. 31, 1966, pp. 100-105.
Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany; XP002291483 BRN 926470 abstract and Osman: Kolor. ERT., vol. 11, 1969, p. 118.
Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany; XP002291484 BRN 311062 abstract & Pinnow; Wiskott: Chem. Ber., vol. 32, 1899, p. 900.
Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany; XP002291485 BRN 189489 abstract & Foster: J. Chem. Soc., 1957, pp. 4687-4688.
Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany; XP002291490 BRN 326965 abstract & V. Walter; Kessler: J. Prak. Chem., vol. 2, No. 74, 1906, p. 198.
Kumar et al., “Cyanoethylation of Benzimidazoles: Synthesis & Biological Activities of Some New1-(beta-Cyanoethyl) benzimidazoles & Their Derivatives”, Indian Journal of Chemistry, Oct. 1985, vol. 24B, p. 1098-1101.
Lindberg, et al., “Long-Time Persistence of Superantigen-Producing Staphylococcus aureus Strains in the Intestinal Microflora of Healthy Infants”, Pediatric Research 48:741-747 (2000).
McDonnell, et al., 7-Hydroxynaphthalen-l-yt-Urea and -Amide Antagonists of Human Vanilloid Receptor 1′; Bioorganic & Medicinal Chemistry Letters 14 (2004), pp. 531-534.
Musso, et al., “Indanylidenes. 1 . Design and Synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a Potent, Centrally Acting Muscle Relaxant with Antiinflammatory and Analgesic Activity”; J. Med. Client 2003, 46, pp. 399-408.
Patent Abstracts of Japan vol. 2000, No. 07, Sep. 29, 2000 & JP 2000 095767 A (Takeda Chem Ind Ltd), Apr. 4, 2000.
Sasaki, et al., “Prevention of collagen-induced arthritis with the superantigen Staphylococcal enterotoxin B”, Patho-physiology 4:25-31 (1997), only p. 25 provided.
Soos, et al., “Treatment PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis”, J Neuroimmunology 43:39-44 (1993), only p. 39 provided.
Willitzer, H. et al., “Synthese und antivirale Wirsamkeit von substituierten 5-Ureido- und 5-Thioureidobenzimidazolderivaten” Pharmazie, Veb Verlag Volk und Gesundheit. Berlin, Germany vol. 33, No. 1, Jan. 1978, pp. 30-38, XP002209435 ISSN: 0031-7144 English Abstract is cited as Accession No. 1978:424221.
STN International, File CAPLUS, accession No. 1978:424221, document No. 89:24221, Willitzer et al., “Synthesis and antiviral activity of substituted 5-ureido- and 5-thioureidobenzimidazole derivates”, & Pharmazie (1978), 33(1) 30-8.
STN International File CAPLUS, accesssion No. 1958:50566, document No. 52-50566, Foster, R. “1-Ethyl-2-methyl-5-nitrobenzimidazole” & Journal of the Chem. Society, Abstracts (1957) 4687-8.
STN International , file CHEMCATS, Accession No. 2000:912544, Apr. 24, 2003, CHS 0297096, 1H-Benzimidazole-1-acetamide, N-[3-(trifluoromethyl)phenyl]-CAS Registry No. 294669-15-1.
STN International, file CHEMCATS, Accession No. 2000 :532079, Apr. 23, 2003, BAS 0238979,1H-Benzimidazole-1-acetamide, N-(3-chlorophenyl)-CAS Registry No. 116488-26-7.
STN International, file CHEMCATS, Accession No. 2001:10738, Apr. 24, 2003, NS11937, 1H-Indole-3-butanamide, N-(4-methylphenyl)-CAS Registry No. 313550-48-0.
STN International, file CHEMCATS, Accession No. 2001:1505160, Apr. 29, 2003, AG-690/40696518,1H-Benzimidazole-l-acetamide, N-(2,3-dichlorophenyl)-, CAS Registry No. 332384-60-8.
STN International, file CHEMCATS, Accession No. 2002:2035573, Jul. 9, 2002, ASN 1816063,1H-Benzimidazole-l-acetamide, N-(3-chloro-4-methylphenyl)—CAS Registry No. 332908-87-9.
STN International, file CHEMCATS, Accession No. 2002:2042451, Jul. 9, 2002, ASN 4428244,1H-Benzimidazole-l-acetamide,N-(5-amnino-2-methylp

Affiliated with

Also associated with

Rating

Benzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2689603